Summary of the annual general meeting announcement of the company

Summary of report is based on the annual general meeting announcement of the company with the appreciation and welcoming all the members in 53^rd annual General Meeting of the company that is attended on the behalf of Chairman of the company and according to the Compliances and regulations of Companies Act, Bangladesh. All the financial statements are being examined by independent external auditors for the period of 2018 to 2019. The report is based on the operation management activities and all the actions of the management and affairs of the company from management to their employees all the data are based on the performance screening of the company. The financial statement of company and operations of the company give a true picture of investment and growth in the company as the employees are contributing their part of efforts to gain their success in the market. In this meeting, it is addressed by the chairman of company Samuel S. Chowdhury to dream that the entire shareholder and other employees of the company will continue to contribute their effort to gain the success of the company. All will work will continue to done according to the rules and regulations that are implemented by founder and Chairman of company Samson Edge Chowdary, who is not here between the people who are working for the company and employees, will contribute according to his instructions to gain the investment in the company.

The director report of the company shows that the member of company is incorporated with the companies at 2015 of Kenya as private limited company and the shares of company is based on the capital of 8 billion. The director’s report shows that there are different investment officer holders such as Ketengala, Machakoas County, Nairobi, Kenya. Principal activity of company shows that the manufacturing and selling of pharmaceutical company is based on the East African Community and the people living in this region are using these medicines.

The plant that is implemented to produce 2 billion tablets and capsules for 3 millions of liquid is estimated that would be revenue generated from this project is 4 million and the cost required is actively underway that is enough to invest in the plant. The project is listed as equity investment will be 8 million and 9 million will be loan financing. Management is appreciating workers and employees to work whole heartedly in this project to gain success.